Patents
Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
08/1993
08/03/1993US5232917 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
08/03/1993CA1320946C 11 .beta.-phenyl-4,9,15-estratrienes their manufacture and pharmaceut ical preparations containing same
07/1993
07/22/1993WO1993014107A1 Process for preparing 3-acylestratrienes and acylbenzenes
07/22/1993CA2127274A1 Process for preparing 3-acylestratrienes and acylbenzenes
07/13/1993US5227375 Androstanediones, estrogen-dependent diseases, anticancer
07/06/1993US5225569 Process for precursors to calcitriol and related compounds
06/1993
06/30/1993EP0549318A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same
06/30/1993EP0548884A1 Biphosphonate derivative
06/30/1993EP0548824A1 Novel tricyclic steroid analogs
06/30/1993EP0548793A2 Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor
06/29/1993CA1319681C Platinum derivatives and cancer treatments
06/27/1993CA2086026A1 Bisphosphonate derivative
06/24/1993WO1993012083A1 22-oxacholecalciferol derivative and production thereof
06/24/1993WO1993011772A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same
06/24/1993DE4143142A1 New 3-methyl sulphonyl hydrazono-steroid derivs. have antiandrogen activity - used to treat benign prostate hyperplasia and androgen dependent prostate carcinoma
06/24/1993CA2117332A1 Glycosylated steroid acid derivatives for transport across biological membranes and process for making same
06/21/1993CA2085830A1 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors
06/21/1993CA2085819A1 Novel tricyclic steroid analogs
06/10/1993WO1993010741A2 Sex steroid activity inhibitors
06/09/1993EP0545409A1 Liquid crystals with end groups containing more than one silane group
06/09/1993EP0321572B1 Pregnane derivatives and process for their preparation
06/08/1993US5218109 Steroid compounds
06/07/1993CA2084562A1 Liquid crystals with (polysila) alkyl wing groups
06/01/1993US5216015 Compounds having hypocholesterolemic properties
06/01/1993US5215972 Internal nitrogen salts; antichloresterol agents
05/1993
05/27/1993WO1993010141A2 Angiostatic steroids
05/27/1993CA2425846A1 Angiostatic steroids
05/25/1993CA1318315C Ester of ascorbic acid 2-phosphate
05/18/1993CA1317932C 9.,11.beta.-substituted and 11.beta.-substituted estranes
05/05/1993EP0539466A1 Pt-CONTAINING COMPOUND, PROCESS FOR ITS PREPARATION, AND APPLICATION OF SUCH COMPOUNDS.
05/04/1993CA1317283C Steroidal 17–-silyl ethers and process to corticoids and progesterones
04/1993
04/29/1993WO1993007883A1 Derivatized oligonucleotides having improved uptake and other properties
04/27/1993US5206415 Modulation of gamma-aminobutyric acid receptor channel function
04/21/1993EP0423293B1 Decorative composition
04/20/1993US5204337 Estrogen nucleus derivatives for use in inhibition of sex steroid activity
04/07/1993EP0535595A2 Manufacture and use of novel glycosides of catechol estrogens
03/1993
03/31/1993EP0533703A1 Steroids which inhibit angiogenesis
03/23/1993US5196542 Phospholipase A2 inhibitors
03/23/1993US5196411 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors
03/23/1993CA1314871C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
03/23/1993CA1314870C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
03/18/1993WO1993005063A1 Steroid sulphatase inhibitors
03/04/1993WO1993003732A1 Gaba receptor modulators
02/1993
02/24/1993EP0528485A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors
02/24/1993EP0528209A1 Process for preparing intermediates for vitamin D derivatives and novel compounds obtained thereby
02/23/1993CA1313864C Phospholipid conjugates and their preparation
02/17/1993CA2067265A1 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors
02/16/1993US5187299 Cyclic hydrocarbons with an aminoalkyl sidechain
02/16/1993CA1313653C 7-substituted 19-nor steroids; process for preparing them; their use as drugs and pharmaceutical compositions containing them
02/02/1993US5183815 Bone acting agents
01/1993
01/26/1993US5182396 1-hydroxyvitamin d derivatives
01/26/1993US5182393 Process for precursors to calcitriol and related compounds
01/26/1993US5182381 Intermediates for 3-keto-19-nor-Δ4,9 -steroids
01/05/1993US5177064 Targeted drug delivery via phosphonate derivatives
12/1992
12/29/1992US5175320 Anticholesterol agents
12/29/1992US5175154 Antiobesity, antidiabetic, antilipemic, anticholesterol agents
12/24/1992DE4120124A1 Cholesterol derivs. prodn. in one-pot process - by treatment of protected halo:alkanol with magnesium-anthracene and reaction with electrophilic steroid
11/1992
11/24/1992US5166139 Antiinflammatory agents
11/24/1992CA1310631C 17.alpha.-HALOGEN-VINYLE-STRANES
11/10/1992CA1310009C Ester prodrugs of steroids
10/1992
10/20/1992US5157031 Method for prophylaxis of obesity
10/20/1992CA1309088C 17.beta.-(CYCLOPROPYLOXY)ANDROST-5-EN-3.beta.-OL AND RELATED COMPOUNDS USEFUL ASC -- -LYASE INHIBITORS
10/14/1992EP0378563B1 Conversion of steroidal 17-cyanohydrins to corticoids
09/1992
09/30/1992WO1992017185A1 Targeted drug delivery via mixed phosphate derivatives
09/30/1992EP0506388A1 1-Hydroxyvitamin D derivatives
09/30/1992CA2108041A1 Targeted drug delivery via mixed phosphate derivatives
09/29/1992CA1308095C 11.beta.-ARYLESTRADINENES, THE PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
09/17/1992WO1992015604A1 Anti-testosterone compounds and method of use thereof
09/16/1992EP0503388A1 Pregna-21-oic acid esters
09/15/1992US5147859 Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them
09/08/1992US5145874 Cyclic hydrocarbons with an aminoalkyl sidechain
09/05/1992CA2061906A1 Novel steroid derivative
09/03/1992WO1992014746A1 Starting compounds for preparing calcitriol and its derivatives, method for preparing these starting compounds and intermediate products for this method
09/03/1992WO1992014493A1 Non-protein intracellular receptor binding conjugates and a method of use thereof
09/01/1992US5144017 Steroids
08/1992
08/20/1992DE4105503A1 Ausgangsverbindungen zur herstellung von calcitriol sowie dessen abkoemmlingen, verfahren zur herstellung dieser ausgangsverbindungen sowie zwischenprodukte fuer dieses verfahren Starting compounds for the production of calcitriol and its derivatives, process for manufacturing output, of such and intermediates for this process
08/06/1992WO1992012989A1 New sterol esters and sterol phosphorus compounds
08/06/1992WO1992012983A1 A method of fluorinating by using n-fluoropyridinium pyridine heptafluorodiborate
07/1992
07/29/1992EP0496520A1 Novel bone acting agents
07/23/1992CA2059421A1 Bone acting agents
07/21/1992US5132299 Antigestagenic, antiglucocorticoid
06/1992
06/30/1992US5126488 2β,19-methyleneamino bridged steroids as aromatase inhibitors
06/30/1992US5126330 Sialosyl cholesterol and neuropathy remedy comprising the same
06/17/1992EP0489779A1 Ophthalmic composition
06/17/1992EP0356454B1 Cyclic hydrocarbons with an aminoalkyl sidechain
06/11/1992WO1992009619A1 2β,19-METHYLENEAMINO BRIDGED STEROIDS AS AROMATASE INHIBITORS
06/09/1992US5120847 Chemical intermediate which can be dehydrohalogenation
06/02/1992US5118671 Complexes of aescin, β-sitosterol or cholesterol, and phospholipids and pharmaceutical compositions containing them
06/02/1992CA1302401C Process for the preparation of 21-hydroxy-20-keto-delta__ -steroids and new intermediate compounds formed in this process
05/1992
05/26/1992US5116983 Dehydrogenation process intermediates
05/26/1992US5116830 Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses
05/20/1992EP0485392A1 Androgen derivatives for use in the inhibition of sex steroid activity
05/20/1992EP0428707A4 Steroid modified oligonucleotides
05/12/1992US5112998 Intermediates for vitamin D3
05/12/1992CA1300601C Estrane and androstane derivatives, process for producing them and preparations containing these compounds
04/1992
04/21/1992US5106963 For liposome immunology
03/1992
03/19/1992WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM
03/19/1992DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them
03/19/1992CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds
03/18/1992EP0308412B1 16$g(a)-METHYLATION PROCESS
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16